UC Berkeley researchers started mice on the drug at 20 months and report they also kept strength and memory. Published in Nature.
Recap by typeshit. Full story at Morning Overview on MSN.
A short item claims a newer group of weight loss drugs beats Ozempic, without naming the drugs or the data behind the claim.
The digital health doctor shares a take on GLP-1 therapy paired with lifestyle change and digital programs, calling the finding unsurprising.
The obesity medicine specialist told a Fall Clinical 2026 panel that sleep apnea, MASH and heart coverage can open GLP-1 access, and that retatrutide could reach market next year.
In a 12-week study of 245 adults, Omada reports its members cut body fat percentage about twice as much as usual care. Results go to WOC 2026 in Boston.
A short TikTok on storing mixed peptide vials. It gives no source or details, and the handling advice is unverified.
The 80-week Lancet trial of 1,152 adults saw 47% on the 12 mg dose lose at least 20% of their weight, with more nausea and diarrhea than placebo.
Loading…